信州大学HOMEENGLISH交通・キャンパス案内

研究者総覧研究者総覧

研究者、研究内容などで検索
項目別検索はこちら

山内 一由  ヤマウチ カズヨシ

教員組織学術研究院(保健学系)電話番号0263-37-2368
教育組織医学部 保健学科 病因・病態検査学FAX番号
職名教授メールアドレスyamauchi@shinshu-u.ac.jp
住所〒390-8621 長野県松本市旭3-1-1ホームページURL

プロフィール

研究分野
病態医化学
病態検査学
境界医学 病態検査学
所属学会
所属学会
American Association for Clinical Chemistry
国際臨床化学会
日本臨床検査自動化学会
日本臨床検査学教育協議会
生物試料分析科学会
日本臨床検査医学会
日本臨床化学会

所属学会役職担当
2010- , 日本臨床検査自動化学会 , 評議員
2009- , 日本臨床化学会 , 理事
2009- , 日本臨床検査学教育協議会 , 評議員
2004- , 日本臨床検査医学会 , 評議員
学歴
取得学位
博士(工学) , 信州大学
受賞学術賞
2011 , 黒住医学研究振興財団第19回研究助成金 , 髄液中の異常リポ蛋白の解析とその臨床的意義
2008 , 日本臨床検査医学会優秀賞 , 髄液中のアポリポ蛋白Eの性状と機能に関する研究
2008 , 財)ホクト生物科学振興財団 (財)ホクト生物科学振興財団研究助成 , シアル化アポリポ蛋白E定量法の確立とシアル化アポリポ蛋白Eとβアミロイドの相互作用に関する研究
2004 , 公益信託臨床検査医学研究振興基金研究助成 , 脳神経組織で産生されるアポリポ蛋白Eの代謝β-Amyloidとの相互作用に関する研究
1999 , 日本臨床化学会学術賞 , 髄液中のApolipoprotein Eに関する研究

研究活動業績

研究業績(著書・
発表論文等)
書籍等出版物
染色法のすべて
医歯薬出版 2021(Mar.)


臨床検査法提要改訂35版
2020(May)


臨床検査法提要 改訂第34版
金原出版 2016(Mar.)


最新臨床検査学講座臨床化学検査学
医歯薬出版 2016(Mar.)


新版臨床免疫学第3版
講談社 2014(Dec.)


メディカルサイエンス臨床化学検査学
近代出版 2014(Jan.)


臨床検査学エッセンスノート 臨床生物化学分析検査
メジカルビュー 2013(Dec.)


臨床検査学エッセンスノート臨床病因・生体防御検査
メジカルビュー 2013(Nov.)


臨床検査学エッセンスノート臨床形態検査
メジカルビュー 2013(Oct.)


標準臨床検査学 検査機器総論 検査管理総論
医学書院 2013(Feb.)
Author:山内一由


髄液中のアポリポ蛋白とアルツハイマー病
臨床検査 2012(Jan.)
Author:山内一由


最新染色法のすべて
医歯薬出版株式会社 2011(Mar.)
Author:山内一由


脂質転送蛋白とコレステロール逆転送系
臨床検査 2010(Apr.)
Author:山内一由


臨床検査法提要
2010(Apr.)
Author:山内一由


臨床検査の現場と連携した教育・研究体制の実現―信州大学医学部保健学科の試みと今後の課題―
臨床検査学教育 2010(Mar.)
Author:奥村伸生,熊谷俊子,山内一由,本田孝行


臨床検査の自動化と臨床検査技師教育
2010(Feb.)
Author:山内一由


髄液中のアポリポ蛋白Eの臨床的意義
検査と技術 2009(Sep.)
Author:山内一由


髄液中のシアル化アポリポ蛋白Eの性状
臨床病理 2009(May)
Author:山内一由


学会レビュー「第59回日本電気泳動学会総会」
Medical Technology 2009(Jan.)
Author:山内一由


Helicobacter pylori 感染による胃病変形成とIL-18
臨床免疫・アレルギー科 2008(Jan.)
Author:山内一由,山岡吉生


「検体採取の基礎知識」最新検査マニュアル
照林社 2007(Jan.)
Author:山内一由,藤田清貴,櫻林郁之介


脳脊髄液中のアポリポ蛋白E(apoE)とアルツハイマー病
臨床化学 2006(Jan.)
Author:戸塚実,山内一由


「検体採取の基礎知識」ナースのための検査マニュアルPart 1
照林社 2005(Jan.)
Author:山内一由,藤田清貴,櫻林郁之介


Isoform-Specific Effects on the Interaction of Apolipoprotein E with β-Amyloid: implication of the mechanism by which apolpipoprotein E contributes to development of Alzheimerz's disease.
2001(Mar.)
Author:山内一由


Automation and New Technology in the Clinical Chemistry
1990(Oct.)
Author:Shozo Nomoto,Kazuyoshi Yamauchi,Moritoshi Sato,F. William,Sunderman, Jr


論文
Redox index of Cys-thiol residues of serum apolipoprotein E and its diagnostic potential.
Bioscience Reports 2021(Aug.)


A novel variant fibrinogen, AaE11del, demonstrating the importance of AaE11 residue in thrombin binding
Int J Hematol 2021(Jul.)


Recombinant gY278H Fibrinogen Showed Normal Secretion from CHO Cells, but a Corresponding Heterozygous Patient Showed Hypofibrinogenemia
Int J Mol Sci 2021(May)


Cut-off values of serum IgG4 among three reagents, including a novel IgG4 reagent: a multicenter study
Sci Rep 2021(Mar.)


Balance capability and smell identification are associated with cognitive function in middle-aged persons with type 2 diabetes
DIABETOLOGIA,63(SUPPL 1::1:SI):S455-S456 2020(Sep.)
Author:Suzuki, H, Midorikawa, M, Suzuki, Y, Sato, H, Nemoto, K, Yamauchi, K, Sugano, Y, Osaki, Y, Iwasaki, H, Sekiya, M, Yahagi, N, Hada, Y, Arai, T, Shimano, H


The redox status of cysteine thiol residues of apolipoprotein E impacts on its lipid interactions
Biological chemistry,401(5):617-627 2020(Feb.)
Author:Yamauchi, Kazuyoshi, Kawakami, Yasushi
Abstract:Redox-mediated modulation of cysteine (Cys) thiols has roles in various pathophysiological functions. We recently found that formation of disulfide-linked complexes of apolipoprotein (apo) E3 prevented apoE3 from irreversible oxidation. In this report, the influence of modification of Cys thiols in apoE2 and apoE3 on interactions with lipids was investigated. The apoE redox status was examined by a band-shift assay using a maleimide compound, and interactions with lipids were evaluated by a kinetic assay using dimyristoyl-snglycero-3-phosphocholine (DMPC) and non-denaturing polyacrylamide gel electrophoresis. A reduction in DMPC clearance activity of apoE2 and apoE3 but not apoE4 was observed. Although hydrogen peroxide-induced oxidation decreased the clearance activity of the isoforms, apoE2 showed the greatest residual activity. Both Cys thiol masking and dimerization decreased the activity of apoE2 and apoE3 but not apoE4. In contrast, apoAII preincubation markedly increased the activity (apoE2 > apoE3 > apoE4), in accordance with the formation of apoE-AII and apoAII-E2-AII complexes. ApoAII preincubation also reduced the particle size of apoEDMPC liposome complexes, especially


Evaluation of a novel serum IgG4 assay and determination of reference interval for the Japanese population
Clin Chim Acta 2020(Feb.)


Evaluation of a novel serum IgG4 assay and determination of reference interval for the Japanese population
Clinica chimica acta; international journal of clinical chemistry,501:136-141 2019(Nov.)
Author:Usami, Yoko, Ichihara, Kiyoshi, Uehara, Takeshi, Sugano, Mitsutoshi, Ishimine, Nau, Kawasaki, Kenji, Yamauchi, Kazuyoshi, Hamano, Hideaki, Honda, Takayuki
Abstract:[BACKGROUND] IgG4-related disease (IgG4-RD) is a new syndrome characterized by elevated serum IgG4 concentration and tissue infiltration of IgG4-positive plasma cells. Here, we evaluated the analytical performance of a new IgG4 assay reagent featuring a wide dynamic range, highly specific monoclonal antibody, and the reversed passive latex agglutination assay and determined the IgG4 reference interval (RI) for the Japanese population. [METHODS] Performance evaluations were conducted on precision, linearity, sensitivity, interference, and method comparison with The Binding Site (TBS) and Siemens reagents. The RI was derived by the parametric method from 619 apparently healthy Japanese 18 to 65 years of age. [RESULTS] Between-day precisions ranged from 1.99 to 5.52 CV%. Linearity was confirmed up to 5.0 g/l. The limit of quantitation was 0.085 g/l. Interfering substances did not significantly influence values. Method comparison among the 3 reagents yielded correlation coefficients between 0.973 and 0.988. Values for the new reagent matched those of TBS reagent except at a higher concentration range, where reactivity dissociated. The RI was 0.11-1.21 g/l without distinction by s


臨床検査学教育における客観的臨床能力試験の有用性
臨床検査学教育,11(2):188-194 2019(Sep.)
Author:服部, 圭一朗, 會田, 雄一, 山内, 一由, 二宮, 治彦


Redox equilibrium of serum apolipoprotein E3: A buffering effect of disulfide-linked complexes against oxidative stress on apolipoprotein E3-containing lipoproteins
Bioscience reports,39(4) 2019(Apr.)
Author:Yamauchi, Kazuyoshi, Iwasaki, Shio, Kawakami, Yasushi
Abstract:Reversible redox modification of cysteine thiols is crucial for protecting proteins from irreversible detrimental change. However, the physiological significance of the redox modification of apolipoprotein (apo) E is unclear. Here, we hypothesized that the disulfide-linked complexes of apoE3 corresponding to the representative reversible-modified apoE3 play a protective role against oxidative stress. The effects of disulfide bond formation on oxidative stress on apoE3 were evaluated with a band-shift assay. Maleimide-labeled apoE3 and unlabeled apoE3 were defined as the reduced (r)-apoE3 and non-reduced (nr)-apoE3 forms, respectively. Hydrogen peroxide-induced oxidation decreased for r-apoE3 but increased for nr-apoE3. Induction of apoE3-AII complex formation with excess of apoAII markedly suppressed the oxidative stress-induced increase in nr-apoE3 ( <0.001) and enhanced homodimer formation. The apoE3-AII complex was more dominant in high-density lipoprotein (HDL) than in very low-density lipoprotein. Under oxidative stress, HDL showed a significant decrease, rather than an increase, in nr-apoE3 levels with a concomitant significant increase in apoE3-AII levels ( <0.005). This f


Redox status of serum apolipoprotein E and its impact on HDL cholesterol levels
Clinical Biochemistry,50(13-14):777-783 2017(Sep. 01)
Author:Kazuyoshi Yamauchi, Yuka Ebihara, Yasushi Kawakami
Abstract:Background Apolipoprotein E (apoE) is closely involved in the pathogenesis of apoE-related diseases, such as Alzheimer's disease and cardiovascular disease. The redox modulation of cysteine-thiols in a protein is involved in various pathophysiological regulations however, that of apoE has not been studied in detail. Herein, we devised an analytical method to determine the redox status of serum apoE and assessed its relation to serum cholesterol levels and apoE phenotype. Methods The present method was based on a band shift assay, using a photocleavable maleimide-conjugated polyethylene glycol. Results The basic characteristics of the present method were found to be satisfactory to determine the redox status of serum apoE quantitatively. Serum apoE was separated into its reduced-form (r-), non-reduced-form (nr-), apoE-AII complex, and homodimer using this method. R-apoE could be detected as a 40-kDa band, whereas nr-apoE remained as monomeric apoE. R-apoE displayed a preference for VLDL however, the levels showed the correlation with HDL-cholesterol levels (p < 0.005). Redox status of serum apoE was significantly different among apoE phenotypes. The quantitative ratios of nr-apoE to total apoE in serum from subjects with apoE4/E3 were higher than in serum from subjects with apoE3/E3 (p < 0.0001) and apoE3/E2 (p < 0.001). Conclusion The redox status of serum apoE might be related to the synthesis of HDL. The information concerning the redox status of serum apoE provided by the present method may be a potent indicator to evaluate various apoE-related diseases.


Impact of TLR 2, TLR 4-activation on the Expression of ABCA1 and ABCG1 in Raw Cells
ANNALS OF CLINICAL AND LABORATORY SCIENCE,47(4):436-446 2017(Jul.)
Author:Kana Suzuki, Yasushi Kawakami, Kazuyoshi Yamauchi
Abstract:Toll-like receptors (TLR) activation is thought to modulate the macrophage cholesterol efflux and contribute to the atherosclerosis progression; however, the precise pathophysiological mechanism remains unclear. We investigated the effects of TLR2-and TLR4-activation on the expression of the ATP-binding cassette (ABC) transporters ABCA1 and ABCG1 in a mouse macrophage cell line, Raw 264.7. Both TLR2-and TLR4-activation upregulated the expression of ABCA1 mRNA but downregulated that of ABCG1 mRNA. These alterations may be mainly regulated by the following 3 cascades: (1) the TLR/myeloid differentiation primary-response protein 88/Liver X receptor pathway, which upregulated the ABCA1 mRNA; (2) NF-kappa B pathway, which downregulated the ABCG1 mRNA, and (3) the p38 pathway, which upregulated and stabilized ABCA1 mRNA. These cascades are involved in a complex crosstalk and result in the upregulation of ABCA1 mRNA without a change in ABCA1 protein and the down-regulation of ABCG1 mRNA leading to the increase in ABCG1 protein. These alterations, especially the induction of ABCG1 protein, may be closely involved with the development of atherosclerosis.


The Asian project for collaborative derivation of reference intervals: (2) results of non-standardized analytes and transference of reference intervals to the participating laboratories on the basis of cross-comparison of test results
CLINICAL CHEMISTRY AND LABORATORY MEDICINE,51(7):1443-1457 2013(Jul.)
Author:Kiyoshi Ichihara, Ferruccio Ceriotti, Mori Kazuo, Yang-Yang Huang, Yoshihisa Shimizu, Haruki Suzuki, Masami Kitagawa, Kazuyoshi Yamauchi, Sadao Hayashi, Chia-Chun Tsou, Yoshikazu Yamamoto, Shigeo Ishida, Linda Leong, Michitaka Sano, Hwan Sub Lim, Akira Suwabe, Hee-Yeon Woo, Keiya Kojima, Yoshio Okubo
Abstract:Background: The 2009 Asian multicenter study for derivation of reference intervals (RIs) featured: 1) centralized measurements to exclude reagent-dependent variations; 2) inclusion of non-standardized analytes (hormones, tumor makers, etc.) in the target; and 3) cross-check of test results between the central and local laboratories. Transferability of centrally derived RIs for non-standardized analytes based on the cross-check was examined. Methods: Forty non-standardized analytes were centrally measured in sera from 3541 reference individuals recruited by 63 laboratories. Forty-four laboratories collaborated in the cross-check study by locally measuring aliquots of sera from 9 to 73 volunteers (average 22.2). Linear relationships were obtained by the reduced major-axis regression. Error in converting RIs using the regression line was expressed by the coefficient of variation of slope b[CV(b)]. CV(b) <10% was set as the cut-off value allowing the conversion. The significance of factors for partitioning RIs was determined similarly as in the first report. Results: Significant sex-, age-, and region-related changes in test results were observed in 17, 15, and 11 of the 40 analytes, respectively. In the cross-comparison study, test results were not harmonized in the majority of immunologically measured analytes, but their average CV(b)s were <10% except for total protein, cystatin C, CA19-9, free thyroxine, and triiodothyronine. After conversion, 74% of centrally derived RIs were transferred to each local laboratory. Conclusions: Our results point to the feasibility of: 1) harmonizing test results across different laboratories; and 2) sharing centrally derived RIs of non-standardized analytes by means of comparative measurement of a set of commutable specimens.


Waldenström macroglobulinemia transforming from t (11;18) (q21;q21) -negative gastric MALT lymphoma after systemic dissemination.
Rinsho Byori 2012(Jun.)
Author:Yamauchi, Kazuyoshi


Characterization of CIA-1, an Ambler Class A Extended-Spectrum beta-Lactamase from Chryseobacterium indologenes
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY,56(1):588-590 2012(Jan.)
Author:Takehisa Matsumoto, Mika Nagata, Nau Ishimine, Kenji Kawasaki, Kazuyoshi Yamauchi, Eiko Hidaka, Eriko Kasuga, Kazuki Horiuchi, Kozue Oana, Yoshiyuki Kawakami, Takayuki Honda
Abstract:An Ambler class A beta-lactamase gene, bla(CIA-1), was cloned from the reference strain Chryseobacterium indologenes ATCC 29897 and expressed in Escherichia coli BL21. The bla(CIA-1) gene encodes a novel extended-spectrum beta-lactamase (ESBL) that shared 68% and 60% identities with the CGA-1 and CME-1 beta-lactamases, respectively. bla(CIA-1)-like genes were detected from clinical isolates. In addition to the metallo-beta-lactamase IND of Ambler class B, C. indologenes has a class A ESBL gene, bla(CIA-1), located on the chromosome.


Pathophysiological Investigation of the Gastric Surface Mucous Gel Layer of Patients with Helicobacter pylori Infection by Using Immunoassays for Trefoil Factor Family 2 and Gastric Gland Mucous Cell-Type Mucin in Gastric Juice
DIGESTIVE DISEASES AND SCIENCES,56(12):3498-3506 2011(Dec.)
Author:Seiko Kubota, Kazuyoshi Yamauchi, Mitsutoshi Sugano, Kenji Kawasaki, Atsushi Sugiyama, Kenji Matsuzawa, Taiji Akamatsu, Yasukazu Ohmoto, Hiroyoshi Ota
Abstract:Background The trefoil factor family (TFF) 2 protein is produced by gastric gland mucous cells (GMCs), and the secreted TFF2 shares a mucosal barrier function with GMC-type mucin. Recently, we presented an enzyme-linked immunosorbent assay (ELISA) method for measurement of GMC-type mucin in the gastric juice. Aims We aimed to develop an ELISA for TFF2 and to assess pathophysiological changes in the gastric surface mucous gel layer (SMGL) of patients with Helicobacter pylori infection. Methods The distribution of TFF2 and GMC-type mucin in the SMGL was immunohistochemically determined. The ELISA for TFF2 was based on a polyclonal goat antibody. Recombinant TFF2 was employed to prepare the calibrators. TFF2 and GMC-type mucin in the gastric juice in healthy individuals (n = 33) and patients with gastritis (n = 37), gastric ulcer (n = 16), and duodenal ulcer (n = 10) were assayed using ELISA. Results TFF2 and GMC-type mucin were immunohistochemically co-localized in the gastric SMGL and GMCs. The TFF2 levels in the patients were significantly higher than those in the healthy individuals. Further, the TFF2 levels in the H. pylori-positive patients were significantly higher than those in the H. pylori-negative patients, and decreased after the eradication of the infection. GMC-type mucin levels showed a tendency similar to that of TFF2 levels. Conclusions The upregulation of TFF2 and GMC-type mucin secretion may reflect the response of the gastric mucosa to H. pylori-induced injuries. TFF2 and GMC-type mucin secreted into the SMGL may protect the gastric mucosa against H. pylori.


Factor H gene variants in Japanese: Its relation to atypical hemolytic uremic syndrome
MOLECULAR IMMUNOLOGY,49(1-2):48-55 2011(Oct.)
Author:Saki Mukai, Yoshihiko Hidaka, Masako Hirota-Kawadobora, Kazuyuki Matsuda, Noriko Fujihara, Yuka Takezawa, Seiko Kubota, Kenichi Koike, Takayuki Honda, Kazuyoshi Yamauchi
Abstract:Mutations and polymorphisms of factor H gene (FH1)are known to be closely involved in the development of atypical hemolytic uremic syndrome (aHUS). Several groups have identified disease risk mutations and polymorphisms of FH1 for the development of aHUS, and have investigated frequencies of aHUS in a number of ethnic groups. However, such studies on Japanese populations are limited. In the present study, we analyzed FH1 in Japanese aHUS patients and healthy volunteers, and examined whether those variants impacted on a tendency for the development of aHUS in Japanese populations. Similar to previous studies, we found that a high frequency of FH1 mutations, located in exon 23 of FH1, encodes short consensus repeat 20 in C-terminal end of factor H molecule in patients with aHUS (40%), but not in healthy volunteers. Interestingly, no significant differences in frequency of well-known disease risk polymorphisms for aHUS were observed between healthy volunteers and aHUS patients. Our results suggested that although FH1 mutations relates to the development of Japanese aHUS in accordance with other ethnic studies, other factor may be required for factor H polymorphism to be a risk factor of Japanese aHUS. (C) 2011 Elsevier Ltd. All rights reserved.


Detection of chymase-digested C-terminally truncated apolipoprotein A-I in normal human serum
JOURNAL OF IMMUNOLOGICAL METHODS,369(1-2):51-58 2011(Jun.)
Author:Yoko Usami, Kazuyuki Matsuda, Mitsutoshi Sugano, Nau Ishimine, Yuriko Kurihara, Tamaki Sumida, Kazuyoshi Yamauchi, Minoru Tozuka
Abstract:In atherosclerotic artery walls, mast cells, an inflammatory cell, are activated and secrete some proteases including chymase. Chymase, a chymotrypsin-like protease, cleaves the C-terminus of apolipoprotein A-I (apoA-I) at Phe225. This cleavage reduces the ability of apoA-I to promote the efflux of cellular cholesterol. The aim of this study is to detect C-terminally truncated apoA-I in normal human serum. For this purpose, we generated a monoclonal antibody that specifically recognizes C-terminally truncated apoA-I by immunizing mice with a peptide that corresponds to human apoA-I amino acid residues 216-225. The monoclonal antibody, termed 16-4 mAb, selectively reacted with recombinant C-terminally truncated apoA-I, but not recombinant full-length apoA-I. A two-dimensional electrophoresis analysis also indicated that only two out of six spots that contained apoA-I fragments and had a molecular mass of 26 kDa after chymase digestion reacted with the 16-4 mAb. We detected an extremely small amount of C-terminally truncated apoA-I in normal human serum by concentrating the serum through affinity chromatography using a 16-4 mAb-conjugated resin, and then performing Western blot analysis. The 16-4 mAb could be useful to examine whether C-terminally truncated apoA-I is associated with the progression of atherosclerosis. (C) 2011 Elsevier B.V. All rights reserved.


Quantitative monitoring of single nucleotide mutations by allele-specific quantitative PCR can be used for the assessment of minimal residual disease in patients with hematological malignancies throughout their clinical course
CLINICA CHIMICA ACTA,412(1-2):53-58 2011(Jan.)
Author:Chiaki Taira, Kazuyuki Matsuda, Yuka Kamijyo, Kazuo Sakashita, Fumihiro Ishida, Toshiko Kumagai, Kazuyoshi Yamauchi, Nobuo Okumura, Takayuki Honda
Abstract:Background: Monitoring of minimal residual disease (MRD) in patients with hematological malignancies is important for evaluating the patients' therapeutic response and risk of relapse. Single nucleotide mutations associated with leukemogenesis can be considered as applicable MRD markers. Methods: We developed an allele-specific quantitative polymerase chain reaction (AS-qPCR) for FLT3 2503G>T, KIT2446G>T, and KIT2447A>T and compared the change in the expression levels of the FLT3 or KIT mutations assessed by AS-qPCR to those of the RUNX1-RUNX1T1 fusion gene and WT1 by conventional quantitative PCR. Results: The AS-qPCR using primers including template-mismatched nucleotide or template-mismatched nucleotide plus locked nucleic acid substituted nucleotide provided higher selectivity for mutant nucleotides. The change in the expression levels of the FLT3 or KIT mutations at the time of relapse and just after hematopoietic stem cell transplantation correlated well with that of the RUNX1-RUNX1T1 fusion gene and WT1. Moreover, during complete remission, only AS-qPCR could detect low-level expression of residual mutations. Conclusions: The AS-qPCR for analyzing single nucleotide mutations contributes to the monitoring of MRD in patients without recurrent fusion gene throughout the clinical course and thus broadens the spectrum of patients in whom MRD can be monitored. (C) 2010 Elsevier B.V. All rights reserved.


In vitro transcription of compound heterozygous hypofibrinogenemia Matsumoto IX; first identification of FGB IVS6 deletion of 4 nucleotides and FGG IVS3-2A > G causing abnormal RNA splicing
CLINICA CHIMICA ACTA,411(17-18):1325-1329 2010(Sep.)
Author:Fumiko Terasawa, Yuka Kamijyo, Noriko Fujihara, Kazuyoshi Yamauchi, Toshiko Kumagai, Takayuki Honda, Satoshi Shigematsu, Nobuo Okumura
Abstract:Background: We reported a case of hypofibrinogenemia Matsumoto IX (M IX) caused by a novel compound heterozygous mutation involving an FGB IVS6 deletion of 4 nucleotides (Delta 4b) (three T, one G; between FGB IVS6-10 and -16) and FGG IVS3-2A/G, which are both identified for the first time. To examine the transcription of mRNA from the M IX gene, we cloned the wild-type and mutant genes into expression vectors. Methods: The vectors were transfected into CHO cells and transiently produced wild-type, B beta-, or gamma-mRNA in the cells. The mRNAs amplified with RT-PCR were analyzed by agarose gel electrophoresis and nucleotide sequencing. Results: The RT-PCR product from FGB IVS6 Delta 4b showed aberrant mRNA that included both introns 6 and 7, and that from FGG IVS3-2G showed two aberrant mRNAs, a major one including intron 3 and a minor in which intron 3 was spliced by a cryptic splice site in exon 4. We speculated that the aberrant mRNAs are degraded before translation into proteins, and/or translated variant chains are subjected to quality control and degraded in the cytoplasm. Conclusion: The reduced plasma fibrinogen level of the M IX patient was caused by abnormal RNA splicing of one or both of the FGB and FGG genes. (C) Elsevier B.V. All rights reserved.


Identification of N-homocysteinylated apolipoprotein Al in normal human serum
ANNALS OF CLINICAL BIOCHEMISTRY,47(Part 5):453-459 2010(Sep.)
Author:N. Ishimine, Y. Usami, S. Nogi, T. Sumida, Y. Kurihara, K. Matsuda, K. Nakamura, K. Yamauchi, N. Okumura, M. Tozuka
Abstract:Background: In human serum, a portion of homocysteine (Hcy) exists as an N-linked form to the epsilon-amino group of protein lysine residues. N-homocysteinylated proteins differ structurally and functionally from native proteins. The present study strives to develop detection and potential semi-quantification methods for N-homocysteinylated apolipoprotein Al (N-HcyapoAl) in human serum. Methods: Serum treated with or without cysteamine was supplied to isoelectric focusing (IEF) followed by an immunoblot using an anti-apoAl antibody. Cysteamine treatment increased the isoelectric point for N-Hcy-apoAl, but not for unmodified apoAl, due to the presence of -SH group(s) derived from Hcy and the absence of a cysteine residue in the apoAl molecule. N-Hcy-apoAl was semi-quantified from the scanned immunoblot pattern via a computer. Results: After cysteamine treatment, N-Hcy-apoAl in the serum was identified by IEF at the position with a higher pl value compared with intact apoAl. The reproducibility (between assays) of the semi-quantification method was 19.1 % CV (coefficient of variation) for an average ratio 5.9% of N-Hcy-apoAl to the whole apoAl in the serum. Approximately 1.0-7.4% of apoAl was N-homocysteinylated in the serum obtained from 27 healthy subjects. Neither the ratio of N-Hcy-apoAl nor its concentration, calculated by total apoAl concentration, indicated correlation with the so-called total (free and S-linked) Hcy concentration. Conclusions: We directly found that a portion of apoAl in the serum undergoes homocysteinylation in an N-linkage manner, and used this to develop a potential semi-quantification method for N-Hcy-apoAl.


A C-terminal amino acid substitution in the gamma-chain caused by a novel heterozygous frameshift mutation (Fibrinogen Matsumoto VII) results in hypofibrinogenaemia
THROMBOSIS AND HAEMOSTASIS,104(2):213-223 2010(Aug.)
Author:Noriko Fujihara, Ayumi Haneishi, Kazuyoshi Yamauchi, Fumiko Terasawa, Toshiro Ito, Fumihiro Ishida, Nobuo Okumura
Abstract:We found a novel hypofibrinogenemia designated as Matsumoto VII (M-VII), which is caused by a heterozygous nucleotide deletion at position g.7651 in FGG and a subsequent frameshift mutation in codon 387 of the gamma-chain. This frameshift results in 25 amino acid substitutions, late termination of translation with elongation by 15 amino acids, and the introduction of a canonical glycosylation site. Western blot analysis of the patient's plasma fibrinogen visualised with anti-gamma-chain antibody revealed the presence of two extra bands. To identify the extra bands and determine which of the above-mentioned alterations caused the assembly and/or secretion defects in the patient, 11 variant vectors that introduced mutations into the cDNA of the gamma-chain or gamma'-chain were transfected into Chinese hamster ovary cells. In vitro expression of transfectants containing gamma Delta 7651A and gamma Delta 7651A/399T (gamma Delta 7651A with an amino acid substitution of 399Asn by Thr and a variant lacking the canonical glycosylation site) demonstrated a reduction in secretion to approximately 20% of the level seen in the transfectants carrying the normal gamma-chain. Furthermore, results from other transfectants demonstrated that eight aberrant residues between 391 and 398 of the M-VII variant, rather than the 15 amino acid extension or the additional glycosylation, are responsible for the reduced levels of assembly and secretion of M-VII variant fibrinogen. Finally, the results of this study and our previous reports demonstrate that the fibrinogen gamma-chain C-terminal tail (388-411) is not necessary for protein assembly or secretion, but the aberrant amino acid sequence observed in the M-VII variant (especially 391-398) disturbs these functions.


Analysis of plasmin generation and clot lysis of plasma fibrinogen purified from a heterozygous dysfibrinogenemia, bGly15Cys (Hamamatsu II).
Blood Coagul Fibrinolysis,20(8):726-732 2009(Dec.)
Author:Kamijyo, Y, Hirota-Kawadobora, M, Yamauchi, K, Terasawa, F, Honda, T, Ikeya, M, Okumura, N


Crucial roles of Helicobacter pylori infection in the pathogenesis of gastric cancer and gastric mucosa-associated lymphoid tissue (MALT) lymphoma
Rinsho Byori,57(9):861-869 2009(Sep.)
Author:Ota, H, Asano, N, Yamauchi, K, Akamatsu, T


H. pylori 感染と胃癌, 胃MALTリンパ腫
臨床病理,57(9):861-869 2009(Sep.)
Author:太田, 浩良, 浅野, 直子, 山内, 一由, 赤松, 泰次


Functional analysis of heterozygous plasma dysfibrinogens derived from two families of gammaArg275Cys and three families of gammaArg275His, and haplotype analysis for these families
Rinsho Byori,57(7):651-658 2009(Jul.)
Author:Kamijyo, Y, Hirota-Kawadobora, M, Fujihara, N, Wakabayashi, S, Matsuda, K, Yamauchi, K, Terasawa, F, Okumura, N, Honda, T


Recombinant variant fibrinogens substituted at residues gnmma326Cys and ganmma339Cys demonstrated markedly impaired secretion of assembled fibrinogen.
Thromb Res 2009(May)
Author:Haneishi, A, Terasawa, F, Fujihara, N, Yamauchi, K, Okumura, N, Katsuyama, T


Laboratory appraisal of optimal gaseous conditions for growth of zoonotic Helicobacter felis ATCC 49179.
Microbiology and Immunology,53(5):251-258 2009(May)
Author:Shiohara, M, Kawakubo, M, Matsumoto, T, Kumagai, T, Yamauchi, K, Oana, K, Ota, H, Kawakami, Y


Characterization of sialo-apolipoprotein E in human cerebrospinal fluid
Rinsho Byori,57(5):436-444 2009(May)
Author:Yamauchi, K


Sialic Acid Moiety of Apolipoprotein E and Its Impact on the Formation of Lipoprotein Particles in Human Cerebrospinal Fluid.
Clinica Chimica Acta,402(1-2):61-66 2009(Apr.)
Author:Kawasaki, K, Ogiwara, N, Sugano, M, Okumura, N, Yamauchi, K


Phylogeny of a novel "Helicobacter heilmannii" organism from a Japanese patient with chronic gastritis based on DNA sequence analysis of 16S rRNA and urease genes.
J Microbiol,47(2):201-207 2009(Apr.)
Author:Matsumoto, T, Kawakubo, M, Shiohara, M, Kumagai, T, HIdaka, E, Yamauchi, K, Oana, K, Matsuzawa, K, Ota, H, Kawakami, Y


Cryptic insertion into 11q23 of MLLT10 not involved in t(1;15;11;10)(p36;q11;q23;q24) in infant acute biphenotypic leukemia.
Cancer Genet Cytogenet,15(190(2)):113-120 2009(Apr.)
Author:Matsuda, K, Tanaka, M, Araki, S, Yanagisawa, R, Yamauchi, K, Koike, K


Characterization of cysteine and homocysteine bound to human serum transthyretin.
Clin Chim Acta,402(1-2):61-66 2009(Apr.)
Author:Hanyu, N, Shimizu, T, Yamauchi, K, Okumura, N, Hidaka, H


Simple allele-specific oligonucleotide polymerase chain reaction for the detection of mutations and deletions in the epidermal growth factor receptor gene: Applications of this method for the diagnosis of non-small-cell lung cancer.
Clinica Chimica Acta,401:68-72 2009(Mar.)
Author:Uhara, M, Matsuda, K, Taira, C, Higuchi, Y, Okumura, N, Yamauchi, K


大学院教育とリンクした臨床検査技師卒後教育制度の確立~人材確保と育成を指向した新たな戦略~
臨床検査学教育 2009(Jan.)
Author:山内一由, 奥村伸生, 太田浩良, 本田孝行


Clinical Assessment of Novel ChromID ESBL Agar Plates for Detection of ESBL Producers in the Family Enterobacteriaceae.
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi,20(1):1-9 2009(Jan.)
Author:Kasuga, E, Matsumoto, T, Hidaka, E, Oguchi, H, Kanai, S, Oana, K, Yamauchi, K, Honda, T, Kawakami, Y


Specific, rapid, and sensitive enzymatic measurement of sphingomyelin, phosphatidylcholine and lysophosphatidylcholine in serum and lipid extracts.
Clin Biochem,41:1211-1217 2008(Aug.)
Author:Hidaka, H, Yamauchi, K, Ohta, H, Akamatsu, T, Honda, T, Katsuyama, T


ウエスタンブロット法によるDダイマー測定試薬の反応性の比較検討
臨床病理,56:449-54 2008(Jun.)
Author:若林早紀, 石川伸介, 廣田(川戸洞, 雅子, 藤原祝子, 上條由夏, 山内一由, 寺澤文子, 奥村伸生, 勝山努


First case of bacteremia due to chromosome-encoded CfxA3-beta-lactamase-producing Capnocytophaga sputigena in a pediatric patient with acute erythroblastic leukemia.
Eur J Med Res,31(13(3)):133-135 2008(Mar.)
Author:Matsumoto, T, Matsubara M, Oana K, Kasuga E, Suzuki T, Hidaka E, Shigemura T, Yamauchi K, Honda T, Ota H, Kawakami Y


Sialic acid moiety of apolipoprotein E3 at Thr194 affects its interaction with β-amyloid1–42 peptides.
Clin Chim Acta,388(1-2):123-129 2008(Feb.)
Author:Sugano, M, Yamauchi K, Kawasaki K, Tozuka M, Fujita K, Okumura N, Ota H
Abstract:Background: The interaction between apolipoprotein (apo) E and beta-amyloid (A beta) is associated with the development of Alzheimer's disease (AD); however, the details remain unknown. ApoE in cerebrospinal fluid is extensively sialylated, and sialylation of certain proteins are known to modulate biological function. We investigated the effects of a sialic acid moiety of apoE on the apoE-A interaction. Methods: We prepared normal apoE3 and its mutant (Thr(194) -> Ala) and analyzed their interactions with A beta(1-42) by using the surface plasmon resonance (SPR) assay. In addition, we per-formed the SPR assay by using apoE-containing lipoproteins treated with neuraminidase. We also assessed the effect of the mutation on the interaction of apoE3 with liposomes. Results: The binding avidity of the mutant apoE3(#) was approximately 50% that of normal apoE3 (p<0.0001). The binding avidity of the apoE-containing lipoproteins for A beta(1-42) reduced after neuraminidase treatment. Conclusions: We suggest that AD development is controlled not only by the apoE isoforms but also by the posttranslational modifications in apoE, such as those in the sialic acid moieties, which are abundant in apoE derived from the brain. (c) 2007 Elsevier B.V All rights reserved.


骨髄移植後のキメリズム解析を不可能にした再発時付加染色体異常
臨床血液,49 2008(Feb.)
Author:樋口由美子, 伊藤俊朗, 松田和之, 樋口司, 日高惠以子, 今川英里, 宇原美帆, 中澤英之, 石田文宏, 山内一由, 佐野健司, 勝山努


Regulation of Interleukin-18 in Helicobacter Infection.
J Immunol,180:1211-1217 2008(Jan.)
Author:Yamauchi, K, Coi, Il-Ju, Lu, H, Ogiwara, H, Graham, DY, Yamaoka, Y


Quantitative analysis of the effect of Helicobacter pylori on the expressions of SOX2, CDX2, MUC2, MUC5AC, MUC6, TFF1, TFF2, and TFF3 mRNAs in human gastric carcinoma cells.
Scand J Gastroenterol,43:25-33 2008(Jan.)
Author:Matsuda, K, Yamauchi, K, Matsumoto, T, Sano, K, Yamaoka, Y, Ota, H


FISH法で診断しえたmyeloid sarcomaの1例
臨床病理,55:1084-1087 2007(Dec.)
Author:今川英里, 松田和之, 日高惠以子, 宇原美帆, 上原剛, 佐野健司, 山内一由


In vitro expression of β-thalassaemia gene (IVS I-1 G-->C) reveals complete inactivation of the normal 5’ splice site and alternative aberrant RNA splicing.
Ann Clin Biochem,44:573-578 2007(Nov.)
Author:Fujihara, N, Yamauchi, K, Hirota-Kawadobora, M, Ishikawa, S, Tozuka, M, Ishii, E, Katsuyama, T, Okumra, N, Taniguchi, S


日常検査で遭遇する低フィブリノーゲン血症の原因推定とヘテロ型フィブリノーゲン異常症・欠損症の凝固スクリーニング検査結果の検討
臨床病理,55:989-995 2007(Nov.)
Author:廣田雅子, 石川伸介, 藤原祝子, 若林早紀, 上條由夏, 山内一由, 寺澤文子, 奥村伸生, 勝山努


Acquisition of loss of the wild-type NRAS locus with aggressive disease progression in a patient with juvenile myelomonocytic leukemia and a heterozygous NRAS mutation.
Haematologica,92:1576-1578 2007(Nov.)
Author:Matsuda, K, Nakazawa, Y, Sakashita, K, Shiohara, M, Yamauchi, K, Koike, K


Helicobacter pylori environmental interactions: effect of acidic conditions on H. pylori-induced gastric mucosal interleukin-8 production.
Cell Microbiol,9:2457-2469 2007(Oct.)
Author:Ju, Choi I, Fujimoto, S, Yamauchi, K, Graham, DY, Yamaoka, Y


Analysis of human serum lipoprotein lipid composition using maldi-tof mass spectrometry.
Ann Clin Lab Sci,37:213-221 2007(Aug.)
Author:Hidaka H, Hanyu N, Sugano M, Kawasaki K, Yamauchi K, Katsuyama T


A complex karyotype, including a three-way translocation generating a NUP98-HOXD13 transcript, in an infant with acute myeloid leukemia.
Cancer Genet Cytogenet,15(176):137-143 2007(Jul.)
Author:Hidaka, E, Tanaka, M, Matsuda, K, Ishikawa-Matsumura, M, Yamauchi, K, Sano, K, Honda, T. Wakui K, Yanagisawa, R, Nakazawa, Y, Sakashita, K, Shiohara, M, Ishii, E, Koike, K


Spontaneous improvement of hematologic abnormalities in patients having juvenile myelomonocytic leukemia with specific RAS mutations.
Blood,109:5477-5480 2007(Jun.)
Author:Matsuda, K, Shimada, A, Yoshida, N, Ogawa, A, Watanabe, A, Yajima, S, Iizuka, S, Yanai, F, Kawasaki, K, Yanagimachi, M, Kikuchi, A, Ohtsuka, Y, Hidaka, E, Yamauchi, K, Tanaka, M, Yanagisawa, R, Nakazawa, Y, Shiohara, M, Manabe, A, Kojima, S, Koike, K


Transmission via the face is one route of methicillin-resistant Staphylococcus aureus cross-infection within a hospital.
Am J Infect Control,35:126-130 2007(Mar.)
Author:Kuramoto-Chikamatsu, A, Honda, T, Matsumoto, T, Shiohara, M, Kawakami, Y, Yamauchi, K, Kato, Y


Quantitative Determination of Gland Mucous Cells-type Mucin Using a Monoclonal Antibody, HIK1083: Its Pathophysiological Changes in Human Gastric Juice.
Clin Chim Acta,377:261-267 2007(Feb.)
Author:Kubota, S, Yamauchi, K, Kumagai, T, Sugano, M, Kawasaki, K, Tozuka, M, Akamatsu, T, Matsuzawa, K, Sugiyama, A, Kurihara, M, Katsuyama, T, Ota, H


Evaluation of BacT/Alert 3D SA bottles for accurate detection of Mycobacteremia with special reference to Mycobacterium abscessus
Eur J Med Res,12:43-46 2007(Jan.)
Author:Kasuga, E, Matsumoto, T, Oana, K, Shiohara, M, Okabe, T, Yamauchi, K, Honda, T, Ota, H, Kawakami, Y


B:b interactions are essential for polymerization of variant fibrinogens with impaired holes ”a”.
J Thromb Haemost,:2352-2359 2007(Jan.)
Author:Okumura, N, Terasawa, F, Haneishi, A, Fujiwara, N, Hirota-kawadobora, M, Yamauchi, K, Ota, H, Lord, ST


TFF2 in gland mucous cell mucin in the mucous gel covering normal or damaged gastric mucosa using the Mongolian gerbil model.
Scand J Gastroenterol,41:1390-1397 2006(Dec.)
Author:Suzuki, K, Hayama, M, Nakamura, M, Yamauchi, K, Maruta, F, Miyagawa, S, Ota, H


臨床検査部門のコスト分析- 問題点はどこにあるのか -
臨床病理,54:1127-1135 2006(Nov.)
Author:瀬戸山友一, 山内一由, 勝山努


A case of acute myelogenous leukemia with MLL-AF10 fusion caused by insertion of 5'MLL into 10p12, with concurrent 3'MLL deletion.
Cancer Genet Cytogenet,17:124-130 2006(Nov.)
Author:Matsuda, K, Hidaka, E, Ishida, F, Yamauchi, K, Makishima, H, Ito, T, Suzuki, T, Imagawa, E, Sano, K, Katsuyama, T, Ota, H


First isolation of Dysgonomonas mossii from intestinal juice of a patient with pancreatic cancer.
Arch Med Res,37:914-916 2006(Oct.)
Author:Matsumoto T, Kawakami Y, Oana K, Honda T, Yamauchi K, Okimura Y, Shiohara M, Kasuga E


Analysis of fibrinogen variants at {gamma}387Ile shows that side-chain of {gamma}387 and the tertiary structure of {gamma}C terminal tail are important for not only assembly and secretion of fibrinogen but also lateral aggregation of protofibrils and XIII
Blood,108:1887-1894 2006(Sep.)
Author:Kani, S, Terasawa, F, Yamauchi, K, Tozuka, M, Okumura, N


An immunoglobulin A1 that inhibits lactate dehydrogenase activity, with reversal of inhibition by addition of NADH.
Ann Clin Lab Sci,36:461-468 2006(Sep.)
Author:Fujita K, Sato H, Kameko F, Terasawa F, Okumura N, Sugano M, Yamauchi K, Maekawa M, Sakurabayashi I


Mechanism of IgA-albumin complex formation that affects the fructosamine assay.
J Electrophoresis,50:19-23 2006(Jun.)
Author:Fujita K, Kameko F, Kato Y, Fukushima M, Terasawa F, Sugano M, Yamauchi K, Sato H, Kameko M, Sakurabayashi I


A novel variant fibrinogen, deletion of B beta 111Ser in coiled-coil region, affecting fibrin lateral aggregation
CLINICA CHIMICA ACTA,365(1-2):160-167 2006(Mar.)
Author:N Okumura, F Terasawa, M Hirota-Kawadobora, K Yamauchi, K Nakanishi, S Shiga, S Ichiyama, M Saito, M Kawai, T Nakahata
Abstract:Background: Functional fibrinogen concentration of a male infant showed < 0.50 g/l and we speculated this patient as a dysfibrinogenemia or hypofibrinogenemia. Methods: We analyzed propositus and his parent by DNA sequencing and by thrombin-catalyzed fibrin polymerization for purified plasma fibrinogen. Results: Although functional fibrinogen determinations based on Clauss method showed the marked discrepancy of values among 3 sets of reagent and analyzer, we found a novel heterozygous variant fibrinogen, Kyoto IV, caused by 3-bp deletion in B beta-chain gene corresponding to the deletion of 111Ser located in coiled-coil region. We suggested that the discrepancy of fibrinogen values among 3 assays was caused by the difference in NaCl concentration in reagents for determination and analyzed the polymerization under the conditions of various NaCl concentrations. Although under normal physiological conditions Kyoto IV fibrinogen augmented the polymerization as compared with normal control, in 0.21 mol/l NaCl Kyoto IV fibrinogen showed abruptly impaired polymerization curve compared with normal control. Conclusion: Variant fibrinogen, B beta Delta 111Ser, showed augmented lateral aggregation under normal physiological conditions and the residue located in coiled-coil region, B beta 111Ser, plays an important role in the lateral aggregation. (c) 2005 Elsevier B.V. All rights reserved.


α1,4-N-acetylglucosaminyltransferase mRNA for detection of pancreatic cancer.
Cancer Sci,97:119-126 2006(Feb.)
Author:Ishizone, S, Yamauchi, K, Kawa, S, Suzuki, T, Shimizu, F, Harada, O, Sugiyama, A, Miyagawa, S, Fukuda, M, Nakayama, J


多点感圧センサーシートによる睡眠時無呼吸症候群スクリーニング検査の有用性
臨床病理 2006
Author:岩崎葉子, 小松佳道, 浅和照子, 山内一由, 勝山努


New enzymatic assay using phospholipase D to measure total calcium in serum.
Clin Chem 2005(Jun.)
Author:Sugano M, Yamauchi K, Sugano K, Kawasaki K, Tozuka M, Katsuyama T, Soya H, Tanaka T, Imamura S, Nomoto S


Roles of virD4 and cagG genes in the cag pathogenicity island of Helicobacter pylori using a Mongolian gerbil model.
Gut 2005(May)
Author:Saito H, Yamaoka Y, Ishizone S, Maruta F, Sugiyama A, Graham DY, Yamauchi K, Ota H, Miyagawa S


Functional analysis of recombinant B beta 15C and B beta 15A fibrinogens demonstrates that B beta 15G residue plays important roles in FPB release and in lateral aggregation of protofibrils
JOURNAL OF THROMBOSIS AND HAEMOSTASIS,3(5):983-990 2005(May)
Author:M Hirota-Kawadobora, S Kani, F Terasawa, N Fujihara, K Yamauchi, M Tozuka, N Okumura
Abstract:Background and objectives: Analysis of dysfibrinogens has improved our understanding of molecular defects and their effects on the function of intact fibrinogen. To eliminate the influence of plasma heterozygous molecules, we synthesized and analyzed recombinant-variant fibrinogens. Methods: We synthesized two recombinant-variant fibrinogens with a single amino acid substitution at the 15Gly residue in the Bβ-chain: namely, Bβ 15Cys and Bβ 15Ala. Results: Western blotting analysis of purified fibrinogen revealed the existence of a small amount of a dimeric form only for Bβ 15Cys fibrinogen. For Bβ 15Cys fibrinogen, functional analysis indicated (a) no thrombi n-catalyzed fibrinopeptide B (FPB) release and (b) markedly impaired lateral aggregation in thrombin- and reptilase-catalyzed fibrin polymerizations. For Bβ 15Ala fibrinogen, such analysis indicated slight impairments of both thrombin-catalyzed FPB release and lateral aggregation in thrombin-catalyzed fibrin polymerization, but nearly normal lateral aggregation in reptilase-catalyzed fibrin polymerization. These impaired lateral aggregations were accompanied by thinner fibrin fiber diameters (determined by scanning electron microscopy of the corresponding fibrin clots). Conclusion: We conclude that a region adjacent to Bβ 15Gly plays important roles in lateral aggregation not only in desA fibrin polymerization, but also in desAB fibrin polymerization, and we speculate that the marked functional differences between Bβ 15A and Bβ 15C fibrinogens in FPB release and fibrin polymerization might not only be due to the presence of a substituted cysteine residue in BP I 5C fibrinogen, but also to the existence of disulfide-bonded forms. Finally, our data indicate that the Bβ 15Gly residue plays important roles in FPB release and lateral aggregation of protofibrils.


Natural history of gastric mucosal cytokine expression in Helicobacter pylori gastritis in Mongolian gerbils.
Infect Immun 2005(Apr.)
Author:Yamaoka Y, Yamauchi K, Sugiyama A, Ishizone S, Grahama DY, Maruta F, Murakami M, Katsuyama T


Monitoring of hematopoietic chimerism by short tandem repeats, and the effect of CD selection on its sensitivity.
Clin Chem 2004(Dec.)
Author:Matsuda K, Yamauchi K, Tozuka M, Suzuki T, Sugano M, Hidaka E, Sano K, Katsuyama T


Degradation of pre-beta-high density lipoproteins and their binding activity to human blood monocytes.
Ann Clin Lab Sci 2004(Jul.)
Author:Nakabayashi T, Yamauchi K, Sugano M, Sano K, Tozuka M, Hidaka H


Characterization of factor XII Tenri, a rare CRM-negative factor XII deficiency.
Ann Clin Lab Sci 2004(Mar.)
Author:Fujihara N, Tozuka M, Yamauchi K, Ueno I, Urasawa N, Ishikawa S, Hirota-Kawadobora M, Okumura N, Hidaka H, Katsuyama T


Purification and measurement of HDL3-binding proteins in human peripheral blood mononuclear cells.
Ann Clin Lab Sci 2003(Jul.)
Author:Hidaka H, Tozuka M, Yamauchi K, Ohta H, Nakayama J, Katsuyama T


Characterization of triglyceride rich lipoproteins with very light density by ultracentrifugation and agarose gel electrophoresis using triglyceride- and cholesterol-staining.
Ann Clin Lab Sci 2003(Mar.)
Author:Hidaka H, Tozuka M, Meyer B, Yamauchi K, Sugano M, Nakabayashi T, Katsuyama T


Novel beta-thalassemia trait (IVS I-1 G-->C) in a Japanese family.
Am J Hematol 2003(Jan.)
Author:Fujihara N, Tozuka M, Ueno I, Yamauchi K, Nakagoshi R, Ishikawa S, Hirota M, Ishii E, Katsuyama T


Internalization of beta-amyloid causes downregulation of apolipoprotein E mRNA expression in neuroblastoma cells.
Ann Clin Lab Sci 2003(Jan.)
Author:Yamauchi K, Tozuka M, Hidaka E, Ueno I, Matsuda K, Katsuyama T


‘Severe’ Prader-Willi syndrome with a large deletion of chromosome 15 due to an unbalanced t(15,22)(q14;q11.2) translocation.
Clin Genet 2003(Jan.)
Author:Matsumura M, Kubota T, Hidaka E, Wakui K, Kadowaki S, Yamauchi K, Herzing LB, Nurmi EL, Sutcliffe JS, Fukushima Y, Katsuyama T


血清亜鉛値による亜鉛欠乏症システムの現況:その欠落部への提言
Biomedical Research on Trace Elements 2003
Author:野本昭三, 山内一由, 中林徹雄


Predominant apolipoprotein J exists as lipid-poor mixtures in cerebrospinal fluid.
Ann Clin Lab Sci 2002(Sep.)
Author:Suzuki T, Tozuka M, Yamauchi K, Sugano M, Nakabayashi T, Okumura N, Hidaka H, Katsuyama T, Higuchi K


DNA microarray analysis of T-cell type lymphoproliferative disease of granular lymphocytes.
Br J Hematol 2002(Aug.)
Author:Makishima H, Ishida F, Ito T, Kitano K, Ueno S, Ohmine K, Yamashita Y, Ota J, Ota M, Yamauchi K, Mano H


Quantitative RT-PCR analysis demonstrates that synthesis of the recombinant fibrinogen is dependent on the transcription and synthesis of gamma-chain.
Clin Chim Acta 2002(May)
Author:Hirota M, Tozuka M, Yamauchi K, Hidaka E, Ueno I, Sugano M, Terasawa F, Okumura N, Katsuyama T, Sigematsu H


t(8;21;14)(q22;q22;q24) is anovel variant of t(8;21) with chimeric transcripts of AML1- ETO in acute myelogenous leukemia.
Cancer Genet Cytogenet 2002(Jan.)
Author:Ishida F, Ueno M, Tanaka H, Makishima H, Suzawa K, Hosaka S, Hidaka E, Ishikawa M, Yamauchi K, Kitano K, Kiyosawa K


Isoform-specific effect of apolipoprotein E on endocytosis of beta-amyloid in cultures of neuroblastoma cells.
Ann Clin Lab Sci. 2002(Jan.)
Author:Yamauchi K, Tozuka M, Hidaka H, Nakabayashi T, Sugano M, Katsuyama T


Characterization of an apolipoprotein E3 variant (Arg 145-->His) associated with mild hypertriglyceridemia.
Ann Clin Lab Sci 2001(Apr.)
Author:Hidaka H, Tozuka M, Hidaka E, Yamauchi K, Ota H, Katsuyama T


Evaluation of the fluorescent image analyzer “Image Titer” for quantitative analysis of antinuclear antibodies.
Am J Clin Pathol 2001(Mar.)
Author:Nakabayashi T, Kumagai T, Yamauchi K, Kuramoto A, Fujita K, Hidaka H, Tozuka M


Effect of apolipoprotein AII on the interaction of apolipoprotein E with beta-amyloid: some apo(E-AII) complexes inhibit the internalization of beta-amyloid in cultures of neuroblastoma cells.
J Neurosci Res. 2000(Nov.)
Author:Yamauchi K, Tozuka M, Hidaka H, Nakabayashi T, Sugano M, Kondo Y, Nakagawara A, Katsuyama T


Novel BCR-ABL transcript containing an intronic sequence insert in a patient with Philadelphia-positive acute lymphoblastic leukaemia.
Br J Haematol 2000(Sep.)
Author:Hirota M, Hidaka E, Ueno I, Ishikawa M, Asano N, Yamauchi K, Ishida F, Tozuka M, Katsuyama T


Analysis of hemoglobin and globin chain variants by a commonly used capillary isoelectric focusing method.
Electrophoresis 2000(Aug.)
Author:Sugano M, Hidaka H, Yamauchi K, Nakabayashi T, Higuchi Y, Fujita K, Okumura N, Ushiyama Y, Tozuka M, Katsuyama T


合成基質を用いた液状リパーゼ測定試薬の検討
医学検査 2000
Author:菅野光俊, 山内一由, 広仲英治, 中林徹雄, 日高宏哉, 戸塚実


Clarithromycin 投与が有効であった Mycobacterium gordonae 肺感染症の1例
結核 2000
Author:小泉知展, 山崎善隆, 久保恵嗣, 矢口勇治, 柳沢英二, 山内一由


Higher avidity binding of apolipoprotein (E-AII) complex than of apolipoprotein E monomer to beta-amyloid.
J Neurosci Res 1999(Oct.)
Author:Yamauchi K, Tozuka M, Nakabayashi T, Sugano M, Hidaka H, Kondo Y, Katsuyama T


Genetic analyses in homozygous and heterozygous variants of lactate dehydrogenase-B (H) subunit -LD-B Matsumoto I and II (LD-B W324R)-
Clin Chim Acta 1999(Sep.)
Author:Okumura N, Terasawa F, Ueno I, Oki K, Yamauchi K, Tozuka M, Katsuyama T


Characterization of apolipoprotein E-containing lipoproteins in cerebrospinal fluid: effect of phenotype on the distribution of apolipoprotein E.
Clin Chem 1999(Sep.)
Author:Yamauchi K, Tozuka M, Hidaka H, Hidaka E, Kondo Y, Katsuyama T


Apolipoprotein E in cerebrospinal fluid: relation to phenotype and plasma apolipoprotein E concentrations.
Clin Chem 1999(Apr.)
Author:Yamauchi K, Tozuka M, Nakabayashi T, Sugano M, Hidaka H, Kondo Y, Katsuyama T


自動分析装置での反応過程異常 を契機として見い出したAST 結合性免疫 グロブリンの1例
医学検査 1999
Author:青木義政, 坂口恵理, 櫻井博文, 亀子光明, 山内一由


日立7170型自 動分析装置による血清コルチゾール測定試 薬の検討
医学検査 1998
Author:菅野光俊, 日高宏哉, 山内一由, 広仲英治, 熊谷俊子, 中林徹雄, 戸塚実


アポE4/E3表現型をもつヒト血清リポ蛋白中のアポE とアポE複合体の分布
臨床病理 1997(Dec.)
Author:日高宏哉, 戸塚実, 山内一由, 菅野光俊, 勝山努


HDL-コレステロール直接法お よび沈殿測定法とゲル濾過クロマトグラフィーによ るSlow αリポ蛋白症例の反応性の検討
臨床化学 1997(Sep.)
Author:山内一由, 戸塚実, 日高宏哉, 中林徹雄, 青木義政, 勝山努


日立7170型自動分析装置による免疫グロブリン測定用試薬の検討
日本臨床検査自動化学会会誌 1997
Author:菅野光俊, 日高宏哉, 中林徹雄, 山内一由, 戸塚実, 勝山努


日立7070によるSAA試薬の検討
医学検査 1997
Author:広仲英治, 日高宏哉, 山内一由, 中林徹雄, 菅野光俊, 戸塚実


電気化学発光免疫測定装置ECLusys 2010による甲状腺関連ホルモンの高感度測定
日本臨床検査自動化学会会誌 1997
Author:山内一由, 戸塚実, 日高宏哉, 熊谷俊子, 中林徹雄, 菅野光俊, 大桑孝子, 勝山努


ビリルビン測定用試薬「イアトロT-Bil」,「イアトロD-Bil」の臨床的検討
医学検査 1997
Author:中林徹雄, 菅野光俊, 山内一由, 日高宏哉, 戸塚実


アンバウンド-ビリルビン測定の基礎と問題点
医学検査 1997
Author:小池由子, 荒井園子, 山内一由, 戸塚実


Characterization of hypertriglyceridemia induced by L-asparaginase therapy for acute lymphoblastic leukemia and malignant lymphoma.
Ann Clin Lab Sci 1997
Author:Tozuka M, Yamauchi K, Hidaka H, Nakabayashi T, Okumura N, Katsuyama T


ベーリングネフェロメータ II(BNII)による改良型リュウマチ因子定量試薬の基礎的検討
医学と薬学 1996
Author:西沢奈美, 山内一由, 櫻井博文, 亀子光明


HDL-コレステロール直接法の評価
生物試料分析 1996
Author:日高宏哉, 中林徹雄, 山内一由, 戸塚実, 野本昭三, 勝山努


ラッテクス凝集免疫比濁法(LIA)によるリポ蛋白(a)[Lp(a)]測定用キットの各種自動分析装置による多施設性能検討
日本臨床検査自動化学会会誌 1995
Author:櫻林郁之介, 太田抜徳, 入久巳, 大竹照子, 河合忠, 荒川光江, 猪刈淳, 三宅紀子, 五味邦英, 杉山弘, 安藤泰彦, 間瀬浩安, 町田勝彦, 池田清子, 森三樹雄, 川村憲弥, 中山年正, 山内一由, 河野均也, 関口光夫, 木嶋祥麿, 牧瀬淳子


血清LDHアイソザイム1型が異常高値を持続した胆嚢癌の一例
臨床化学 1991
Author:山内一由, 五十嵐富三男, 中山年正, 吉田行哉, 江藤浩之, 安斎均


液クロと原子吸光を直結させたシステムによる血清亜鉛の分画測定とその結合様式に関する検討
微量金属代謝 1989
Author:野本昭三, 山内一由


講演・口頭発表等
Balance capability and smell identification are associated with cognitive function in middle-aged persons with type 2 diabetes
56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD) 2020(Sep. 21)
Presenter:Suzuki H, Midorikawa M, Suzuki Y, Sato H, Nemoto K, Yamauchi K, Sugano Y, Osaki Y, Iwasaki H, Sekiya M, Yahagi N, Hada Y, Arai T, Shimano H


筑波大学における臨地実習前OSCEの実践と課題
2019年度 日臨技 首都圏支部・関甲信支部医学検査学会(第56回) 2019(Oct. 26)
Presenter:會田 雄一, 山内 一由, 二宮 治彦


臨地実習後の項目別自己評価:OSLE客観評価との関連性の検討
第13回日本臨床検査学教育学会学術大会 2018(Aug. 17)
Presenter:服部 圭一朗, 會田 雄一, 真家 紘一郎, 山内 一由, 森川 一也, 中川 嘉, 吉田 文代, 小池 朗, 二宮 治彦


履修証明プログラム「多職種連携メディカルスタッフ教育プログラム」の普及とコンテンツ更新に関する課題
第11回日本保健医療福祉連携教育学会学術集会 2018(Aug. 11)
Presenter:會田 雄一, 服部 圭一朗, 真家 紘一郎, 関本 道治, 山内 一由, 二宮 治彦, 對間 博之, 佐藤 斉, 門間 正彦, 冨田 和秀, 大橋 ゆかり


大学と病院をつなぐ多職種連携医療専門職養成プログラムの成果
第67回日本医学検査学会 2018(May 12)
Presenter:會田 雄一, 山内 一由, 関本 道治, 真家 紘一郎, 二宮 治彦